The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global In Vitro Diagnostic (IVD) Products Market Research Report 2025
Synopsis
The global market for In Vitro Diagnostic (IVD) Products was valued at US$ 83520 million in the year 2024 and is projected to reach a revised size of US$ 110650 million by 2031, growing at a CAGR of 4.2% during the forecast period.
In Vitro Diagnostic (IVD) tests are a subset of medical devices. In vitro diagnostic products are those reagents, instruments, and systems intended for use in diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. Such products are intended for use in the collection, preparation, and examination of specimens taken from the human body.
In vitro diagnostics are tests that can detect diseases, conditions, or infections. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
The global healthcare spending contributes to ca. 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The IVD market plays a significant role in the HC industry, influencing over 60% of laboratorial decision-making. However, it only accounts for ca. 2% of total HC spending, signifying an enormous potential for cost-effective tests.
The primary driver of growth in the IVD market is the aging of the global population. In addition, prevalence of chronic diseases is anticipated to propel this growth. More, growing demand for point-of-care devices and rapid diagnostic testing and increasing willingness to pay for preventive care testing.
COVID-19 pandemic is expected to continue to positively impact the market in 2020, 2021 and 2022, Due to the relaxation of global epidemic supervision, the reduction of COVID-19 testing in the post-epidemic era will reduce the total market size.
The In Vitro Diagnostics (IVD) market is driven by several key factors, including the rising prevalence of chronic and infectious diseases, advancements in diagnostic technologies, and increasing demand for personalized medicine. Innovations such as next-generation sequencing (NGS), point-of-care testing, and AI-driven diagnostics are transforming the industry by enabling faster, more accurate, and cost-effective testing. Additionally, the growing emphasis on preventive healthcare and the expansion of healthcare access in emerging markets are further fueling market growth. Regulatory support for precision diagnostics and increased investment in R&D also play a significant role in driving the adoption of IVD products globally.
Despite these drivers, the market faces several challenges. Stringent regulatory requirements and the high cost of R&D and clinical validation pose significant barriers for both established players and new entrants. Market saturation in developed regions and price sensitivity in emerging markets make it difficult to balance innovation with affordability. Furthermore, the integration of new diagnostic tools with existing laboratory infrastructure and IT systems can be complex and costly. Lastly, competition from established players and the need for significant capital investment to scale production and distribution add to the challenges for companies operating in this space.
The classification of In-Vitro Diagnostics (IVDs) Products includes Molecular Diagnostics, Immuno Diagnostics, Chemistry Diagnostics, POCT and Other. In 2023, POCT accounted for a share of 24.25% in the global In-Vitro Diagnostics (IVDs) Products market. In addition, this product segment is poised to reach US$ 29524 million by 2030 from US$ 19941 million in 2023.
North Americas is the largest consumption place, with a consumption market share nearly 38.19% in 2023. Following North Americas, APAC is the second largest consumption place with the consumption market share of 32.8%.
This report aims to provide a comprehensive presentation of the global market for In Vitro Diagnostic (IVD) Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Diagnostic (IVD) Products.
The In Vitro Diagnostic (IVD) Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In Vitro Diagnostic (IVD) Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Diagnostic (IVD) Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Abbott
Danaher
Siemens Healthineers
Thermo Fisher Scientific
Sysmex
BioMerieux
QuidelOrtho
Becton Dickinson
Bio-Rad Laboratories
Hologic
LifeScan
Qiagen
Wuhan Easy Diagnosis
Wondfo
KHB
Hotgen
Mindray
Sinocare
Getein Biotech
Segment by Type
Immuno Diagnostics
Chemistry Diagnostics
Molecular Diagnostics
POCT
Others
Segment by Application
Hospital
Laboratory
Household
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Diagnostic (IVD) Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global market for In Vitro Diagnostic (IVD) Products was valued at US$ 83520 million in the year 2024 and is projected to reach a revised size of US$ 110650 million by 2031, growing at a CAGR of 4.2% during the forecast period.
In Vitro Diagnostic (IVD) tests are a subset of medical devices. In vitro diagnostic products are those reagents, instruments, and systems intended for use in diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. Such products are intended for use in the collection, preparation, and examination of specimens taken from the human body.
In vitro diagnostics are tests that can detect diseases, conditions, or infections. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
The global healthcare spending contributes to ca. 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The IVD market plays a significant role in the HC industry, influencing over 60% of laboratorial decision-making. However, it only accounts for ca. 2% of total HC spending, signifying an enormous potential for cost-effective tests.
The primary driver of growth in the IVD market is the aging of the global population. In addition, prevalence of chronic diseases is anticipated to propel this growth. More, growing demand for point-of-care devices and rapid diagnostic testing and increasing willingness to pay for preventive care testing.
COVID-19 pandemic is expected to continue to positively impact the market in 2020, 2021 and 2022, Due to the relaxation of global epidemic supervision, the reduction of COVID-19 testing in the post-epidemic era will reduce the total market size.
The In Vitro Diagnostics (IVD) market is driven by several key factors, including the rising prevalence of chronic and infectious diseases, advancements in diagnostic technologies, and increasing demand for personalized medicine. Innovations such as next-generation sequencing (NGS), point-of-care testing, and AI-driven diagnostics are transforming the industry by enabling faster, more accurate, and cost-effective testing. Additionally, the growing emphasis on preventive healthcare and the expansion of healthcare access in emerging markets are further fueling market growth. Regulatory support for precision diagnostics and increased investment in R&D also play a significant role in driving the adoption of IVD products globally.
Despite these drivers, the market faces several challenges. Stringent regulatory requirements and the high cost of R&D and clinical validation pose significant barriers for both established players and new entrants. Market saturation in developed regions and price sensitivity in emerging markets make it difficult to balance innovation with affordability. Furthermore, the integration of new diagnostic tools with existing laboratory infrastructure and IT systems can be complex and costly. Lastly, competition from established players and the need for significant capital investment to scale production and distribution add to the challenges for companies operating in this space.
The classification of In-Vitro Diagnostics (IVDs) Products includes Molecular Diagnostics, Immuno Diagnostics, Chemistry Diagnostics, POCT and Other. In 2023, POCT accounted for a share of 24.25% in the global In-Vitro Diagnostics (IVDs) Products market. In addition, this product segment is poised to reach US$ 29524 million by 2030 from US$ 19941 million in 2023.
North Americas is the largest consumption place, with a consumption market share nearly 38.19% in 2023. Following North Americas, APAC is the second largest consumption place with the consumption market share of 32.8%.
This report aims to provide a comprehensive presentation of the global market for In Vitro Diagnostic (IVD) Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Diagnostic (IVD) Products.
The In Vitro Diagnostic (IVD) Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In Vitro Diagnostic (IVD) Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Diagnostic (IVD) Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Abbott
Danaher
Siemens Healthineers
Thermo Fisher Scientific
Sysmex
BioMerieux
QuidelOrtho
Becton Dickinson
Bio-Rad Laboratories
Hologic
LifeScan
Qiagen
Wuhan Easy Diagnosis
Wondfo
KHB
Hotgen
Mindray
Sinocare
Getein Biotech
Segment by Type
Immuno Diagnostics
Chemistry Diagnostics
Molecular Diagnostics
POCT
Others
Segment by Application
Hospital
Laboratory
Household
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Diagnostic (IVD) Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Diagnostic (IVD) Products Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immuno Diagnostics
1.2.3 Chemistry Diagnostics
1.2.4 Molecular Diagnostics
1.2.5 POCT
1.2.6 Others
1.3 Market by Application
1.3.1 Global In Vitro Diagnostic (IVD) Products Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Household
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Diagnostic (IVD) Products Market Perspective (2020-2031)
2.2 Global In Vitro Diagnostic (IVD) Products Growth Trends by Region
2.2.1 Global In Vitro Diagnostic (IVD) Products Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 In Vitro Diagnostic (IVD) Products Historic Market Size by Region (2020-2025)
2.2.3 In Vitro Diagnostic (IVD) Products Forecasted Market Size by Region (2026-2031)
2.3 In Vitro Diagnostic (IVD) Products Market Dynamics
2.3.1 In Vitro Diagnostic (IVD) Products Industry Trends
2.3.2 In Vitro Diagnostic (IVD) Products Market Drivers
2.3.3 In Vitro Diagnostic (IVD) Products Market Challenges
2.3.4 In Vitro Diagnostic (IVD) Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Diagnostic (IVD) Products Players by Revenue
3.1.1 Global Top In Vitro Diagnostic (IVD) Products Players by Revenue (2020-2025)
3.1.2 Global In Vitro Diagnostic (IVD) Products Revenue Market Share by Players (2020-2025)
3.2 Global In Vitro Diagnostic (IVD) Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by In Vitro Diagnostic (IVD) Products Revenue
3.4 Global In Vitro Diagnostic (IVD) Products Market Concentration Ratio
3.4.1 Global In Vitro Diagnostic (IVD) Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Diagnostic (IVD) Products Revenue in 2024
3.5 Global Key Players of In Vitro Diagnostic (IVD) Products Head office and Area Served
3.6 Global Key Players of In Vitro Diagnostic (IVD) Products, Product and Application
3.7 Global Key Players of In Vitro Diagnostic (IVD) Products, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Diagnostic (IVD) Products Breakdown Data by Type
4.1 Global In Vitro Diagnostic (IVD) Products Historic Market Size by Type (2020-2025)
4.2 Global In Vitro Diagnostic (IVD) Products Forecasted Market Size by Type (2026-2031)
5 In Vitro Diagnostic (IVD) Products Breakdown Data by Application
5.1 Global In Vitro Diagnostic (IVD) Products Historic Market Size by Application (2020-2025)
5.2 Global In Vitro Diagnostic (IVD) Products Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America In Vitro Diagnostic (IVD) Products Market Size (2020-2031)
6.2 North America In Vitro Diagnostic (IVD) Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America In Vitro Diagnostic (IVD) Products Market Size by Country (2020-2025)
6.4 North America In Vitro Diagnostic (IVD) Products Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Diagnostic (IVD) Products Market Size (2020-2031)
7.2 Europe In Vitro Diagnostic (IVD) Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe In Vitro Diagnostic (IVD) Products Market Size by Country (2020-2025)
7.4 Europe In Vitro Diagnostic (IVD) Products Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Diagnostic (IVD) Products Market Size (2020-2031)
8.2 Asia-Pacific In Vitro Diagnostic (IVD) Products Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific In Vitro Diagnostic (IVD) Products Market Size by Region (2020-2025)
8.4 Asia-Pacific In Vitro Diagnostic (IVD) Products Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro Diagnostic (IVD) Products Market Size (2020-2031)
9.2 Latin America In Vitro Diagnostic (IVD) Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America In Vitro Diagnostic (IVD) Products Market Size by Country (2020-2025)
9.4 Latin America In Vitro Diagnostic (IVD) Products Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Diagnostic (IVD) Products Market Size (2020-2031)
10.2 Middle East & Africa In Vitro Diagnostic (IVD) Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa In Vitro Diagnostic (IVD) Products Market Size by Country (2020-2025)
10.4 Middle East & Africa In Vitro Diagnostic (IVD) Products Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche In Vitro Diagnostic (IVD) Products Introduction
11.1.4 Roche Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott In Vitro Diagnostic (IVD) Products Introduction
11.2.4 Abbott Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 Danaher
11.3.1 Danaher Company Details
11.3.2 Danaher Business Overview
11.3.3 Danaher In Vitro Diagnostic (IVD) Products Introduction
11.3.4 Danaher Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025)
11.3.5 Danaher Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers In Vitro Diagnostic (IVD) Products Introduction
11.4.4 Siemens Healthineers Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025)
11.4.5 Siemens Healthineers Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific In Vitro Diagnostic (IVD) Products Introduction
11.5.4 Thermo Fisher Scientific Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Sysmex
11.6.1 Sysmex Company Details
11.6.2 Sysmex Business Overview
11.6.3 Sysmex In Vitro Diagnostic (IVD) Products Introduction
11.6.4 Sysmex Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025)
11.6.5 Sysmex Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Details
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux In Vitro Diagnostic (IVD) Products Introduction
11.7.4 BioMerieux Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025)
11.7.5 BioMerieux Recent Development
11.8 QuidelOrtho
11.8.1 QuidelOrtho Company Details
11.8.2 QuidelOrtho Business Overview
11.8.3 QuidelOrtho In Vitro Diagnostic (IVD) Products Introduction
11.8.4 QuidelOrtho Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025)
11.8.5 QuidelOrtho Recent Development
11.9 Becton Dickinson
11.9.1 Becton Dickinson Company Details
11.9.2 Becton Dickinson Business Overview
11.9.3 Becton Dickinson In Vitro Diagnostic (IVD) Products Introduction
11.9.4 Becton Dickinson Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025)
11.9.5 Becton Dickinson Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Details
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories In Vitro Diagnostic (IVD) Products Introduction
11.10.4 Bio-Rad Laboratories Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 Hologic
11.11.1 Hologic Company Details
11.11.2 Hologic Business Overview
11.11.3 Hologic In Vitro Diagnostic (IVD) Products Introduction
11.11.4 Hologic Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025)
11.11.5 Hologic Recent Development
11.12 LifeScan
11.12.1 LifeScan Company Details
11.12.2 LifeScan Business Overview
11.12.3 LifeScan In Vitro Diagnostic (IVD) Products Introduction
11.12.4 LifeScan Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025)
11.12.5 LifeScan Recent Development
11.13 Qiagen
11.13.1 Qiagen Company Details
11.13.2 Qiagen Business Overview
11.13.3 Qiagen In Vitro Diagnostic (IVD) Products Introduction
11.13.4 Qiagen Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025)
11.13.5 Qiagen Recent Development
11.14 Wuhan Easy Diagnosis
11.14.1 Wuhan Easy Diagnosis Company Details
11.14.2 Wuhan Easy Diagnosis Business Overview
11.14.3 Wuhan Easy Diagnosis In Vitro Diagnostic (IVD) Products Introduction
11.14.4 Wuhan Easy Diagnosis Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025)
11.14.5 Wuhan Easy Diagnosis Recent Development
11.15 Wondfo
11.15.1 Wondfo Company Details
11.15.2 Wondfo Business Overview
11.15.3 Wondfo In Vitro Diagnostic (IVD) Products Introduction
11.15.4 Wondfo Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025)
11.15.5 Wondfo Recent Development
11.16 KHB
11.16.1 KHB Company Details
11.16.2 KHB Business Overview
11.16.3 KHB In Vitro Diagnostic (IVD) Products Introduction
11.16.4 KHB Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025)
11.16.5 KHB Recent Development
11.17 Hotgen
11.17.1 Hotgen Company Details
11.17.2 Hotgen Business Overview
11.17.3 Hotgen In Vitro Diagnostic (IVD) Products Introduction
11.17.4 Hotgen Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025)
11.17.5 Hotgen Recent Development
11.18 Mindray
11.18.1 Mindray Company Details
11.18.2 Mindray Business Overview
11.18.3 Mindray In Vitro Diagnostic (IVD) Products Introduction
11.18.4 Mindray Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025)
11.18.5 Mindray Recent Development
11.19 Sinocare
11.19.1 Sinocare Company Details
11.19.2 Sinocare Business Overview
11.19.3 Sinocare In Vitro Diagnostic (IVD) Products Introduction
11.19.4 Sinocare Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025)
11.19.5 Sinocare Recent Development
11.20 Getein Biotech
11.20.1 Getein Biotech Company Details
11.20.2 Getein Biotech Business Overview
11.20.3 Getein Biotech In Vitro Diagnostic (IVD) Products Introduction
11.20.4 Getein Biotech Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025)
11.20.5 Getein Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global In Vitro Diagnostic (IVD) Products Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Immuno Diagnostics
Table 3. Key Players of Chemistry Diagnostics
Table 4. Key Players of Molecular Diagnostics
Table 5. Key Players of POCT
Table 6. Key Players of Others
Table 7. Global In Vitro Diagnostic (IVD) Products Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global In Vitro Diagnostic (IVD) Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global In Vitro Diagnostic (IVD) Products Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global In Vitro Diagnostic (IVD) Products Market Share by Region (2020-2025)
Table 11. Global In Vitro Diagnostic (IVD) Products Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global In Vitro Diagnostic (IVD) Products Market Share by Region (2026-2031)
Table 13. In Vitro Diagnostic (IVD) Products Market Trends
Table 14. In Vitro Diagnostic (IVD) Products Market Drivers
Table 15. In Vitro Diagnostic (IVD) Products Market Challenges
Table 16. In Vitro Diagnostic (IVD) Products Market Restraints
Table 17. Global In Vitro Diagnostic (IVD) Products Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global In Vitro Diagnostic (IVD) Products Market Share by Players (2020-2025)
Table 19. Global Top In Vitro Diagnostic (IVD) Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Diagnostic (IVD) Products as of 2024)
Table 20. Ranking of Global Top In Vitro Diagnostic (IVD) Products Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by In Vitro Diagnostic (IVD) Products Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of In Vitro Diagnostic (IVD) Products, Headquarters and Area Served
Table 23. Global Key Players of In Vitro Diagnostic (IVD) Products, Product and Application
Table 24. Global Key Players of In Vitro Diagnostic (IVD) Products, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global In Vitro Diagnostic (IVD) Products Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global In Vitro Diagnostic (IVD) Products Revenue Market Share by Type (2020-2025)
Table 28. Global In Vitro Diagnostic (IVD) Products Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global In Vitro Diagnostic (IVD) Products Revenue Market Share by Type (2026-2031)
Table 30. Global In Vitro Diagnostic (IVD) Products Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global In Vitro Diagnostic (IVD) Products Revenue Market Share by Application (2020-2025)
Table 32. Global In Vitro Diagnostic (IVD) Products Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global In Vitro Diagnostic (IVD) Products Revenue Market Share by Application (2026-2031)
Table 34. North America In Vitro Diagnostic (IVD) Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America In Vitro Diagnostic (IVD) Products Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America In Vitro Diagnostic (IVD) Products Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe In Vitro Diagnostic (IVD) Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe In Vitro Diagnostic (IVD) Products Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe In Vitro Diagnostic (IVD) Products Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific In Vitro Diagnostic (IVD) Products Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific In Vitro Diagnostic (IVD) Products Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific In Vitro Diagnostic (IVD) Products Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America In Vitro Diagnostic (IVD) Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America In Vitro Diagnostic (IVD) Products Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America In Vitro Diagnostic (IVD) Products Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa In Vitro Diagnostic (IVD) Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa In Vitro Diagnostic (IVD) Products Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa In Vitro Diagnostic (IVD) Products Market Size by Country (2026-2031) & (US$ Million)
Table 49. Roche Company Details
Table 50. Roche Business Overview
Table 51. Roche In Vitro Diagnostic (IVD) Products Product
Table 52. Roche Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025) & (US$ Million)
Table 53. Roche Recent Development
Table 54. Abbott Company Details
Table 55. Abbott Business Overview
Table 56. Abbott In Vitro Diagnostic (IVD) Products Product
Table 57. Abbott Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025) & (US$ Million)
Table 58. Abbott Recent Development
Table 59. Danaher Company Details
Table 60. Danaher Business Overview
Table 61. Danaher In Vitro Diagnostic (IVD) Products Product
Table 62. Danaher Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025) & (US$ Million)
Table 63. Danaher Recent Development
Table 64. Siemens Healthineers Company Details
Table 65. Siemens Healthineers Business Overview
Table 66. Siemens Healthineers In Vitro Diagnostic (IVD) Products Product
Table 67. Siemens Healthineers Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025) & (US$ Million)
Table 68. Siemens Healthineers Recent Development
Table 69. Thermo Fisher Scientific Company Details
Table 70. Thermo Fisher Scientific Business Overview
Table 71. Thermo Fisher Scientific In Vitro Diagnostic (IVD) Products Product
Table 72. Thermo Fisher Scientific Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025) & (US$ Million)
Table 73. Thermo Fisher Scientific Recent Development
Table 74. Sysmex Company Details
Table 75. Sysmex Business Overview
Table 76. Sysmex In Vitro Diagnostic (IVD) Products Product
Table 77. Sysmex Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025) & (US$ Million)
Table 78. Sysmex Recent Development
Table 79. BioMerieux Company Details
Table 80. BioMerieux Business Overview
Table 81. BioMerieux In Vitro Diagnostic (IVD) Products Product
Table 82. BioMerieux Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025) & (US$ Million)
Table 83. BioMerieux Recent Development
Table 84. QuidelOrtho Company Details
Table 85. QuidelOrtho Business Overview
Table 86. QuidelOrtho In Vitro Diagnostic (IVD) Products Product
Table 87. QuidelOrtho Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025) & (US$ Million)
Table 88. QuidelOrtho Recent Development
Table 89. Becton Dickinson Company Details
Table 90. Becton Dickinson Business Overview
Table 91. Becton Dickinson In Vitro Diagnostic (IVD) Products Product
Table 92. Becton Dickinson Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025) & (US$ Million)
Table 93. Becton Dickinson Recent Development
Table 94. Bio-Rad Laboratories Company Details
Table 95. Bio-Rad Laboratories Business Overview
Table 96. Bio-Rad Laboratories In Vitro Diagnostic (IVD) Products Product
Table 97. Bio-Rad Laboratories Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025) & (US$ Million)
Table 98. Bio-Rad Laboratories Recent Development
Table 99. Hologic Company Details
Table 100. Hologic Business Overview
Table 101. Hologic In Vitro Diagnostic (IVD) Products Product
Table 102. Hologic Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025) & (US$ Million)
Table 103. Hologic Recent Development
Table 104. LifeScan Company Details
Table 105. LifeScan Business Overview
Table 106. LifeScan In Vitro Diagnostic (IVD) Products Product
Table 107. LifeScan Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025) & (US$ Million)
Table 108. LifeScan Recent Development
Table 109. Qiagen Company Details
Table 110. Qiagen Business Overview
Table 111. Qiagen In Vitro Diagnostic (IVD) Products Product
Table 112. Qiagen Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025) & (US$ Million)
Table 113. Qiagen Recent Development
Table 114. Wuhan Easy Diagnosis Company Details
Table 115. Wuhan Easy Diagnosis Business Overview
Table 116. Wuhan Easy Diagnosis In Vitro Diagnostic (IVD) Products Product
Table 117. Wuhan Easy Diagnosis Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025) & (US$ Million)
Table 118. Wuhan Easy Diagnosis Recent Development
Table 119. Wondfo Company Details
Table 120. Wondfo Business Overview
Table 121. Wondfo In Vitro Diagnostic (IVD) Products Product
Table 122. Wondfo Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025) & (US$ Million)
Table 123. Wondfo Recent Development
Table 124. KHB Company Details
Table 125. KHB Business Overview
Table 126. KHB In Vitro Diagnostic (IVD) Products Product
Table 127. KHB Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025) & (US$ Million)
Table 128. KHB Recent Development
Table 129. Hotgen Company Details
Table 130. Hotgen Business Overview
Table 131. Hotgen In Vitro Diagnostic (IVD) Products Product
Table 132. Hotgen Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025) & (US$ Million)
Table 133. Hotgen Recent Development
Table 134. Mindray Company Details
Table 135. Mindray Business Overview
Table 136. Mindray In Vitro Diagnostic (IVD) Products Product
Table 137. Mindray Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025) & (US$ Million)
Table 138. Mindray Recent Development
Table 139. Sinocare Company Details
Table 140. Sinocare Business Overview
Table 141. Sinocare In Vitro Diagnostic (IVD) Products Product
Table 142. Sinocare Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025) & (US$ Million)
Table 143. Sinocare Recent Development
Table 144. Getein Biotech Company Details
Table 145. Getein Biotech Business Overview
Table 146. Getein Biotech In Vitro Diagnostic (IVD) Products Product
Table 147. Getein Biotech Revenue in In Vitro Diagnostic (IVD) Products Business (2020-2025) & (US$ Million)
Table 148. Getein Biotech Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
Table 152. Authors List of This Report
List of Figures
Figure 1. In Vitro Diagnostic (IVD) Products Picture
Figure 2. Global In Vitro Diagnostic (IVD) Products Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global In Vitro Diagnostic (IVD) Products Market Share by Type: 2024 VS 2031
Figure 4. Immuno Diagnostics Features
Figure 5. Chemistry Diagnostics Features
Figure 6. Molecular Diagnostics Features
Figure 7. POCT Features
Figure 8. Others Features
Figure 9. Global In Vitro Diagnostic (IVD) Products Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global In Vitro Diagnostic (IVD) Products Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Laboratory Case Studies
Figure 13. Household Case Studies
Figure 14. Others Case Studies
Figure 15. In Vitro Diagnostic (IVD) Products Report Years Considered
Figure 16. Global In Vitro Diagnostic (IVD) Products Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global In Vitro Diagnostic (IVD) Products Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global In Vitro Diagnostic (IVD) Products Market Share by Region: 2024 VS 2031
Figure 19. Global In Vitro Diagnostic (IVD) Products Market Share by Players in 2024
Figure 20. Global Top In Vitro Diagnostic (IVD) Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Diagnostic (IVD) Products as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by In Vitro Diagnostic (IVD) Products Revenue in 2024
Figure 22. North America In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America In Vitro Diagnostic (IVD) Products Market Share by Country (2020-2031)
Figure 24. United States In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe In Vitro Diagnostic (IVD) Products Market Share by Country (2020-2031)
Figure 28. Germany In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific In Vitro Diagnostic (IVD) Products Market Share by Region (2020-2031)
Figure 36. China In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America In Vitro Diagnostic (IVD) Products Market Share by Country (2020-2031)
Figure 44. Mexico In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa In Vitro Diagnostic (IVD) Products Market Share by Country (2020-2031)
Figure 48. Turkey In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE In Vitro Diagnostic (IVD) Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Roche Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2020-2025)
Figure 52. Abbott Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2020-2025)
Figure 53. Danaher Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2020-2025)
Figure 54. Siemens Healthineers Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2020-2025)
Figure 55. Thermo Fisher Scientific Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2020-2025)
Figure 56. Sysmex Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2020-2025)
Figure 57. BioMerieux Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2020-2025)
Figure 58. QuidelOrtho Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2020-2025)
Figure 59. Becton Dickinson Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2020-2025)
Figure 60. Bio-Rad Laboratories Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2020-2025)
Figure 61. Hologic Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2020-2025)
Figure 62. LifeScan Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2020-2025)
Figure 63. Qiagen Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2020-2025)
Figure 64. Wuhan Easy Diagnosis Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2020-2025)
Figure 65. Wondfo Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2020-2025)
Figure 66. KHB Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2020-2025)
Figure 67. Hotgen Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2020-2025)
Figure 68. Mindray Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2020-2025)
Figure 69. Sinocare Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2020-2025)
Figure 70. Getein Biotech Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2020-2025)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
